These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9197464)

  • 1. Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate.
    Lores Arnaiz S; Travacio M; Monserrat AJ; Cutrín JC; Llesuy S; Boveris A
    Biochim Biophys Acta; 1997 May; 1360(3):222-8. PubMed ID: 9197464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide metabolism during peroxisome proliferation by fenofibrate.
    Arnaiz SL; Travacio M; Llesuy S; Boveris A
    Biochim Biophys Acta; 1995 Dec; 1272(3):175-80. PubMed ID: 8541349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators.
    Tomaszewski KE; Agarwal DK; Melnick RL
    Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process.
    Lee JN; Dutta RK; Kim SG; Lim JY; Kim SJ; Choe SK; Yoo KW; Song SR; Park DS; So HS; Park R
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):22-7. PubMed ID: 24211584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats.
    Tamura H; Iida T; Watanabe T; Suga T
    Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vivo genotoxic potential of fenofibrate in rats subjected to two-week repeated oral administration.
    Tawfeeq MM; Suzuki T; Shimamoto K; Hayashi H; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Aug; 85(8):1003-11. PubMed ID: 21127841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.
    Fahl WE; Lalwani ND; Watanabe T; Goel SK; Reddy JK
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7827-30. PubMed ID: 6096860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats.
    Karakan T; Kerem M; Cindoruk M; Engin D; Alper M; Akın O
    Turk J Gastroenterol; 2013; 24(2):134-40. PubMed ID: 23934460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferation and lipid peroxidation in rat liver.
    Goel SK; Lalwani ND; Reddy JK
    Cancer Res; 1986 Mar; 46(3):1324-30. PubMed ID: 3943099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in mouse heart by antitumoral drugs: a comparative study of doxorubicin and mitoxantrone.
    Lores Arnaiz S; Llesuy S
    Toxicology; 1993 Jan; 77(1-2):31-8. PubMed ID: 8442016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity?
    Garberg P; Stenius U; Nilsson K; Högberg J
    Carcinogenesis; 1992 Oct; 13(10):1751-8. PubMed ID: 1423834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
    Rao MS; Reddy JK
    Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating efficacy of Rebaudioside A, a diterpenoid on antioxidant and circulatory lipids in experimental diabetic rats.
    Saravanan R; Ramachandran V
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):472-483. PubMed ID: 23792234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
    Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofibrate--racemate and enantiomers: effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study.
    Klinger W; Lupp A; Karge E; Oelschläger H; Rothley D; Danz M; Linss W; Löbel S; Deufel T; Müller M; Klinger M; Kühnel W
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):301-14. PubMed ID: 9784002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidative and anti-inflammatory effects of lipoic acid in rat liver.
    Goraca A; Huk-Kolega H; Kowalczyk A; Skibska B
    Postepy Hig Med Dosw (Online); 2015 Mar; 69():270-6. PubMed ID: 25748617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate.
    Perera MI; Katyal SL; Shinozuka H
    Cancer Res; 1986 Jul; 46(7):3304-8. PubMed ID: 3708564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate and human liver. Lack of proliferation of peroxisomes.
    Gariot P; Barrat E; Mejean L; Pointel JP; Drouin P; Debry G
    Arch Toxicol; 1983 Jun; 53(2):151-63. PubMed ID: 6882216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production.
    Takahashi M; Tsuboyama-Kasaoka N; Nakatani T; Ishii M; Tsutsumi S; Aburatani H; Ezaki O
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G338-48. PubMed ID: 11804856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.